Gilead’s $5B Tubulis Deal Validates ADC Space – Bullish for Sutro Biopharma
Leerink sees major tailwind for Sutro Biopharma and initiates coverage with $38 price target.
Leerink sees major tailwind for Sutro Biopharma and initiates coverage with $38 price target.
Three top execs are leaving The Trade Desk, following the resignation of board member Lise Buyer.
Apple’s first foldable iPhone is coming this September, pricey $2K+, fixes screen issues, opens like an iPad, limited early stock.
Perrigo Co. stock rose on takeover rumors, possibly by Stada Arzneimittel AG. No deal confirmed yet.
Rosenblatt upgrades Arista Networks, citing strong AI demand and faster growth ahead.
Paramount gets $24B from Middle East funds to buy WBD, keeps control, offers perks to shareholders, deal aims to close in 2026.